Is Arcus Biosciences Inc (RCUS) Stock a Smart Value Monday?

The 60 rating InvestorsObserver gives to Arcus Biosciences Inc (RCUS) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 71 percent of stocks in the Healthcare sector, RCUS’s 60 overall rating means the stock scores better than 60 of all stocks.

RCUS has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on RCUS!

See Full RCUS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Arcus Biosciences Inc Stock Today?

Arcus Biosciences Inc (RCUS) stock is down -3.38% while the S&P 500 is higher by 0.3% as of 12:19 PM on Monday, Jun 5. RCUS has fallen -$0.71 from the previous closing price of $21.01 on volume of 1,232,868 shares. Over the past year the S&P 500 has gained 4.22% while RCUS has fallen -9.13%. RCUS lost -$3.85 per share the over the last 12 months. Click Here to get the full Stock Report for Arcus Biosciences Inc stock.